Elixiron Immunotherapeutics (Cayman) Limited (TPEX:7871)

Taiwan · Delayed Price · Currency is TWD

145.50

+6.50 (4.68%)

At close: Sep 7, 2026

TPEX:7871 Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.03	0.03	-1.09	-1.01
Net Debt / Equity Ratio	-1.03	-1.01	-1.02	-0.98
Net Debt / EBITDA Ratio	3.67	4.38	-6.05	-6.34
Net Debt / FCF Ratio	5.07	6.33	-5.18	-7.08
Asset Turnover	0.14	0.09	0.01	-
Quick Ratio	9.36	9.96	0.07	0.04
Current Ratio	9.47	10.03	0.07	0.04
Return on Assets (ROA)	-17.11%	-22.77%	-118.27%	-
Return on Capital Employed (ROCE)	-28.40%	-23.30%	17.40%	16.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Buyback Yield / Dilution	-461.57%	-256.61%	72.30%	-